Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment Effects BOSTON--(BUSINESS WIRE)--Elucid, a medical technology company developing...
There are certain vein problems that women are more susceptible to, so it’s important to counteract these issues by taking...
Secondary endpoint data for once-nightly FT218 further supports previously announced topline data demonstrating clinically meaningful results at 6 g, 7.5...
JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based...
Toronto, Ontario--(Newsfile Corp. - April 16, 2021) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a Canadian leader...
LAS VEGAS, NV / ACCESSWIRE / April 16, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), is pleased to provide an...
NEW YORK, NY / ACCESSWIRE / April 16, 2021 / Many players have come into the COVID-19 return-to-work space. Large...
CHESHIRE, UK / ACCESSWIRE / April 16, 2021 / Synertech, a medical device company aiming to provide simple surgical solutions,...
Oslo, Norway, 16 April 2021 Vistin Pharma ASA will release its first quarter 2021 results on Friday 23rd of April 2021....
UPPSALA, SWEDEN – LIDDS publishes Annual Report for 2020 The Annual Report is attached to this press release and alos...
KANSAS CITY, Mo., April 16, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its first...
-- Adverum to host webcast with key opinion leaders on Sunday, May 2, 2021 at 7:00 AM PT -- REDWOOD CITY, Calif.,...
Seizure Related Benefits noted by caregivers included reduction in frequency, fewer triggers causing seizures, and shorter recovery time when seizure...
TEMPLE CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a...
TORONTO, April 16, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will...
SYDNEY, AUSTRALIA, April 16, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased...
Ublituximab demonstrated superiority versus teriflunomide in reducing annualized relapse rates and MRI brain lesions Ublituximab was generally well tolerated, with...
PETVIVO HOLDINGS, INC Robert J. Folkes MINNEAPOLIS, MN, US, April 16, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV)...
New findings from MS PATHS show that treatment with TYSABRI® (natalizumab) can lead to meaningful improvements in mental and social health compared...
Company to showcase its latest integrated solutions for improving care across the whole transplant journeySOUTH SAN FRANCISCO, Calif., April 16,...